Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GT Biopharma (GTBP) Non-Current Assets (2016 - 2020)

GT Biopharma (GTBP) has disclosed Non-Current Assets for 11 consecutive years, with $84000.0 as the latest value for Q3 2020.

  • On a quarterly basis, Non-Current Assets fell 42.07% to $84000.0 in Q3 2020 year-over-year; TTM through Jun 2021 was $84000.0, a 8.7% decrease, with the full-year FY2019 number at $122000.0, changed N/A from a year prior.
  • Non-Current Assets was $84000.0 for Q3 2020 at GT Biopharma, down from $92000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $254.5 million in Q1 2018 to a low of $3000.0 in Q1 2017.
  • A 5-year average of $60.7 million and a median of $114500.0 in 2019 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: surged 8482000.0% in 2018, then plummeted 99.64% in 2020.
  • GT Biopharma's Non-Current Assets stood at $4000.0 in 2016, then soared by 6344700.0% to $253.8 million in 2017, then tumbled by 90.04% to $25.3 million in 2018, then plummeted by 99.52% to $122000.0 in 2019, then crashed by 31.15% to $84000.0 in 2020.
  • Per Business Quant, the three most recent readings for GTBP's Non-Current Assets are $84000.0 (Q3 2020), $92000.0 (Q2 2020), and $107000.0 (Q1 2020).